BACKGROUND: This study was aimed at determining the frequency and coexistent patterns of high- and medium-risk cardiac sources of embolism (CSE) as defined by the Trial of ORG 10172 in the Acute Stroke Treatment (TOAST) classification system and at investigating how identified CSE contributed to this classification. METHODS: We analyzed data from 2,482 patients with acute cerebral infarctions who registered in the Yonsei Stroke Registry over a 10-year period. Cardiac sources were divided into high- and medium-risk groups based on the TOAST classification. RESULTS: Of the 2,482 patients, 1,130 (46%) underwent echocardiographic studies. At least one CSE was detected in 629 patients (25%). Atrial fibrillation was the most common high-risk CSE. Patent foramen ovale, spontaneous echo contrast and congestive heart failure comprised most of the medium-risk CSE. Atrial fibrillation frequently accompanied coexistent CSE (69%) such as spontaneous echo contrast, congestive heart failure, and left atrial/appendage thrombus, while patent foramen ovale was detected in isolation in more than 90% of the patients. Patients with a high-risk CSE were more likely to be diagnosed with cardioembolism (83%) than patients with only a medium-risk CSE (58%). CONCLUSIONS: Our study elucidated the frequency and various coexistent patterns of CSE in Korean stroke patients as defined by the TOAST classification system. In addition, we have demonstrated a higher correlation between high-risk CSE and cardioembolism than with medium-risk CSE and cardioembolism. (c) 2007 S. Karger AG, Basel
BACKGROUND: This study was aimed at determining the frequency and coexistent patterns of high- and medium-risk cardiac sources of embolism (CSE) as defined by the Trial of ORG 10172 in the Acute Stroke Treatment (TOAST) classification system and at investigating how identified CSE contributed to this classification. METHODS: We analyzed data from 2,482 patients with acute cerebral infarctions who registered in the Yonsei Stroke Registry over a 10-year period. Cardiac sources were divided into high- and medium-risk groups based on the TOAST classification. RESULTS: Of the 2,482 patients, 1,130 (46%) underwent echocardiographic studies. At least one CSE was detected in 629 patients (25%). Atrial fibrillation was the most common high-risk CSE. Patent foramen ovale, spontaneous echo contrast and congestive heart failure comprised most of the medium-risk CSE. Atrial fibrillation frequently accompanied coexistent CSE (69%) such as spontaneous echo contrast, congestive heart failure, and left atrial/appendage thrombus, while patent foramen ovale was detected in isolation in more than 90% of the patients. Patients with a high-risk CSE were more likely to be diagnosed with cardioembolism (83%) than patients with only a medium-risk CSE (58%). CONCLUSIONS: Our study elucidated the frequency and various coexistent patterns of CSE in Korean strokepatients as defined by the TOAST classification system. In addition, we have demonstrated a higher correlation between high-risk CSE and cardioembolism than with medium-risk CSE and cardioembolism. (c) 2007 S. Karger AG, Basel
Authors: Patrick M Pullicino; Leslie A McClure; Virginia J Howard; Virginia G Wadley; Monika M Safford; James F Meschia; Aaron Anderson; George Howard; Elsayed Z Soliman Journal: J Stroke Cerebrovasc Dis Date: 2011-12-03 Impact factor: 2.136
Authors: Patrick M Pullicino; Leslie A McClure; Virginia G Wadley; Ali Ahmed; Virginia J Howard; George Howard; Monika M Safford Journal: Stroke Date: 2009-10-15 Impact factor: 7.914
Authors: Young Dae Kim; Hye Yeon Choi; Hyun Ji Cho; Myoung Jin Cha; Chung Mo Nam; Sang Won Han; Hyo Suk Nam; Ji Hoe Heo Journal: Yonsei Med J Date: 2010-05 Impact factor: 2.759
Authors: Young Dae Kim; Kyung Yul Lee; Hyo Suk Nam; Sang Won Han; Jong Yun Lee; Han-Jin Cho; Gyu Sik Kim; Seo Hyun Kim; Myoung-Jin Cha; Seong Hwan Ahn; Seung-Hun Oh; Kee Ook Lee; Yo Han Jung; Hye-Yeon Choi; Sang-Don Han; Hye Sun Lee; Chung Mo Nam; Eun Hye Kim; Ki Jeong Lee; Dongbeom Song; Hui-Nam Park; Ji Hoe Heo Journal: Yonsei Med J Date: 2015-03 Impact factor: 2.759